{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T16:01:57Z","timestamp":1773763317512,"version":"3.50.1"},"reference-count":0,"publisher":"Press of International Journal of Ophthalmology (IJO Press)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Ophthalmol"],"published-print":{"date-parts":[[2026,4,18]]},"abstract":"<jats:p>AIM: To evaluate nanosilver eye patches versus Atrauman nanosilver dressings for ocular surface trauma.\nMETHODS: This randomized non-inferiority trial (November 2024\u2013April 2025) enrolled 60 patients assessed pre-treatment and on days 1, 7, and 14 post-treatment. The patients were then randomized into treatment (nanosilver eye patches) and control groups (Atrauman nanosilver dressings). Outcomes included wound healing, comfort (Ocular Comfort Index, OCI), and safety. Statistical analyses used t-tests, non-inferiority tests, and Chi-square tests.\nRESULTS: Patient baseline characteristics were comparable between groups, with a mean age of 60.633\u00b110.934 in the treatment group versus 64.933\u00b19.606 in controls, and similar gender distribution (20\/10 vs 17\/13 male\/female). Both groups showed comparable baseline OCI scores (treatment group: 6.100\u00b12.187 vs control group: 6.267\u00b12.303, P=0.775). Following treatment, scores increased significantly at day 1 (treatment group: 9.367\u00b12.251; control group: 9.067\u00b12.212, both P&lt;0.001 vs baseline). Marked improvement was observed by day 7 (treatment group: 4.067\u00b11.929; control group: 3.900\u00b11.918, P&lt;0.001 vs baseline), with complete resolution at day 14 (0.467\u00b10.860 vs 0.467\u00b11.008, P&lt;0.001). The non-inferiority criterion was met. The treatment group showed greater improvement in Grade A wound healing rates (76.67% to 93.33%) compared to controls (80.00% to 86.67%) between 1 and 7d post-treatment. By 14d post-treatment, all patients achieved Grade A healing in both groups, with no Grade C cases observed throughout the study period. No adverse events were reported.\nCONCLUSION: Nanosilver eye patches are non-inferior to Atrauman dressings, offering effective, safe emergency care for ocular trauma.<\/jats:p>","DOI":"10.18240\/ijo.2026.04.16","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T14:09:00Z","timestamp":1773756540000},"page":"764-774","source":"Crossref","is-referenced-by-count":0,"title":["Nanosilver eye patch for ocular surface trauma: a prospective randomised trial and review of the literature"],"prefix":"10.18240","volume":"19","author":[{"name":"PLA General Hospital (PLA Medical School), Beijing 100853, China; Department of Ophthalmology, Hainan Hospital of PLA General Hospital, Sanya 572013, Hainan Province, China","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Qi","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7543","container-title":["International Journal of Ophthalmology"],"original-title":[],"link":[{"URL":"https:\/\/www.ijo.cn\/gjyken\/article\/pdf\/20260416","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T14:09:05Z","timestamp":1773756545000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ijo.cn\/gjyken\/article\/abstract\/20260416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,18]]},"references-count":0,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4,18]]}},"URL":"https:\/\/doi.org\/10.18240\/ijo.2026.04.16","relation":{},"ISSN":["2222-3959","2227-4898"],"issn-type":[{"value":"2222-3959","type":"print"},{"value":"2227-4898","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,18]]}}}